The post $4.6 Billion Bitcoin, Ethereum Options Expire Today: Market Impact appeared on BitcoinEthereumNews.com. The crypto market is bracing for heightened volatility as more than $4.6 billion in Bitcoin and Ethereum options expire today. This pivotal event could dictate short-term price action for both leading assets. Analysts caution that the September expiry carries added weight, historically associated with weaker performance and lower liquidity across digital assets. Bitcoin, Ethereum Options Expiry Looms With $14.6 Billion at Stake Sponsored Bitcoin (BTC) dominates this round of expiring options, with a notional value of $3.38 billion. According to Deribit, total open interest stands at 30,447 contracts. The max pain point, where the greatest number of options expire worthless, is $112,000. Meanwhile, the put-call ratio is 1.41, suggesting an edge for bearish positions and a market leaning toward caution. Bitcoin Expiring Options. Source: Deribit Ethereum faces a similarly crucial expiry with $1.29 billion in notional value. Open interest is 299,744 contracts, with the max pain level at $4,400. The put-call ratio of 0.77 indicates stronger demand for calls (purchases), though analysts observe a significant build-up above the $4,500 strike. Deribit highlighted this skew. “…flows lean more balanced, but calls build up above $4.5K, leaving upside optionality,” Deribit noted. Sponsored Expiring Ethereum Options. Source: Deribit Analysts at Greeks.live highlighted Ethereum’s implied volatility (IV), indicating that short-term IV has surged toward 70%. This suggests heightened expectations for price swings after the Ethereum price corrected over 10% from its recent peak. “Weakness in US equities and the WLFI index has intensified market skepticism,” Greeks.live analysts wrote. In the same way, IV across Bitcoin maturities has rebounded to around 40% after a month-long correction. Notably, this pullback saw the Bitcoin price drop more than 10% from its all-time high. However, analysts see a defensive stance among traders. Evidence of this is accelerating block trading in puts, which account for nearly 30% of today’s options volume. Sponsored… The post $4.6 Billion Bitcoin, Ethereum Options Expire Today: Market Impact appeared on BitcoinEthereumNews.com. The crypto market is bracing for heightened volatility as more than $4.6 billion in Bitcoin and Ethereum options expire today. This pivotal event could dictate short-term price action for both leading assets. Analysts caution that the September expiry carries added weight, historically associated with weaker performance and lower liquidity across digital assets. Bitcoin, Ethereum Options Expiry Looms With $14.6 Billion at Stake Sponsored Bitcoin (BTC) dominates this round of expiring options, with a notional value of $3.38 billion. According to Deribit, total open interest stands at 30,447 contracts. The max pain point, where the greatest number of options expire worthless, is $112,000. Meanwhile, the put-call ratio is 1.41, suggesting an edge for bearish positions and a market leaning toward caution. Bitcoin Expiring Options. Source: Deribit Ethereum faces a similarly crucial expiry with $1.29 billion in notional value. Open interest is 299,744 contracts, with the max pain level at $4,400. The put-call ratio of 0.77 indicates stronger demand for calls (purchases), though analysts observe a significant build-up above the $4,500 strike. Deribit highlighted this skew. “…flows lean more balanced, but calls build up above $4.5K, leaving upside optionality,” Deribit noted. Sponsored Expiring Ethereum Options. Source: Deribit Analysts at Greeks.live highlighted Ethereum’s implied volatility (IV), indicating that short-term IV has surged toward 70%. This suggests heightened expectations for price swings after the Ethereum price corrected over 10% from its recent peak. “Weakness in US equities and the WLFI index has intensified market skepticism,” Greeks.live analysts wrote. In the same way, IV across Bitcoin maturities has rebounded to around 40% after a month-long correction. Notably, this pullback saw the Bitcoin price drop more than 10% from its all-time high. However, analysts see a defensive stance among traders. Evidence of this is accelerating block trading in puts, which account for nearly 30% of today’s options volume. Sponsored…

$4.6 Billion Bitcoin, Ethereum Options Expire Today: Market Impact

For feedback or concerns regarding this content, please contact us at [email protected]

The crypto market is bracing for heightened volatility as more than $4.6 billion in Bitcoin and Ethereum options expire today. This pivotal event could dictate short-term price action for both leading assets.

Analysts caution that the September expiry carries added weight, historically associated with weaker performance and lower liquidity across digital assets.

Bitcoin, Ethereum Options Expiry Looms With $14.6 Billion at Stake

Sponsored

Bitcoin (BTC) dominates this round of expiring options, with a notional value of $3.38 billion. According to Deribit, total open interest stands at 30,447 contracts.

The max pain point, where the greatest number of options expire worthless, is $112,000. Meanwhile, the put-call ratio is 1.41, suggesting an edge for bearish positions and a market leaning toward caution.

Bitcoin Expiring Options. Source: Deribit

Ethereum faces a similarly crucial expiry with $1.29 billion in notional value. Open interest is 299,744 contracts, with the max pain level at $4,400.

The put-call ratio of 0.77 indicates stronger demand for calls (purchases), though analysts observe a significant build-up above the $4,500 strike. Deribit highlighted this skew.

Sponsored

Expiring Ethereum Options. Source: Deribit

Analysts at Greeks.live highlighted Ethereum’s implied volatility (IV), indicating that short-term IV has surged toward 70%. This suggests heightened expectations for price swings after the Ethereum price corrected over 10% from its recent peak.

In the same way, IV across Bitcoin maturities has rebounded to around 40% after a month-long correction. Notably, this pullback saw the Bitcoin price drop more than 10% from its all-time high.

However, analysts see a defensive stance among traders. Evidence of this is accelerating block trading in puts, which account for nearly 30% of today’s options volume.

Sponsored

Analysts Warn of September Weakness

Still, market sentiment is shifting quickly. Greeks.live stressed that September has historically been a challenging month for crypto. Institutional rollovers and quarterly settlements often subdue capital flows.

The prevailing downtrend and declining crypto-related equities make risk aversion the primary theme.

As options near expiry, Bitcoin and Ethereum prices tend to pull toward their max pain levels. For Bitcoin, trading at $111,391 as of this writing means a modest uptick to $112,000. The same goes for Ethereum, which traded for $4,326 at press time.

Sponsored

With today’s third-quarter delivery month, liquidity patterns and rollover activity could amplify volatility in both directions.

Therefore, defensive sentiment may dominate as traders brace for prolonged weakness or a potential breakout once expiry clears. However, the market tends to stabilize after 8:00 UTC when the options expire on Deribit.

Sponsored

The critical question remains whether expiry will pin Bitcoin and Ethereum near their current levels or act as a catalyst for a recovery.

Option dynamics could exert magnetic pressure in the near term, with max pain sitting just above current prices for both BTC and ETH.

If history holds, September may continue to challenge bulls, but the market’s growing defensive posture suggests any surprise upside could be met with equally aggressive repositioning.

Source: https://beincrypto.com/crypto-volatility-bitcoin-ethereum-options-expiring/

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$68,025.33
$68,025.33$68,025.33
-0.70%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09